European Journal of Contraception and Reproductive Health Care最新文献_第7页

Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition. 绝经过渡期间使用52 mg左炔诺孕酮宫内节育器对绝经后影响的妇女观点

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-08-01 DOI: 10.1080/13625187.2023.2202292

Jacques B E Versailles, Sherly Metelus, Alessandra Peloggia, Montas Laporte, Luis Bahamondes, Cassia Juliato

引用次数: 0

Clinical improvement after Essure® devices removal: a systematic review. Essure®器械移除后的临床改善:一项系统综述。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-08-01 DOI: 10.1080/13625187.2023.2236741

Chloe Miguet-Bensouda, Francois Parant, Guillaume Grenet, Emanuele Cerruto, Erdogan Nohuz, Gautier Chene

{"title":"Clinical improvement after Essure® devices removal: a systematic review.","authors":"Chloe Miguet-Bensouda, Francois Parant, Guillaume Grenet, Emanuele Cerruto, Erdogan Nohuz, Gautier Chene","doi":"10.1080/13625187.2023.2236741","DOIUrl":"https://doi.org/10.1080/13625187.2023.2236741","url":null,"abstract":"Purpose: Essure® implant is a permanently implanted minimally invasive birth control device for women (female sterilisation) widely used between 2002 and 2018. Many adverse events were reported by patients. Increasingly removal procedures have been performed in symptomatic patients. However, there is a lack of in-depth studies on clinical improvement after Essure® removal. We aimed to review all clinical studies about symptoms and quality of life (QoL) after removal procedures.Materials and methods: A review of literature in electronic search in Medline and Embase databases from January 2002 to January 2022 using the following keywords: Essure; Essure removal; quality of life; symptomatology improvement.Results: Out of 764 articles in the initial database, 18 clinical studies were eligible for inclusion in our literature review. Overall clinical improvement rates after removal ranged from 21% to 98%. All symptoms were less frequent after Essure® removal, although with large discrepancies between studies. Lack of improvement was reported between 1% to 15% of patients. Rate of patients with improvement of QoL after removal ranged from 58 to 98%. The pain was reported as significantly reduced after the surgery.Conclusions: In the available literature, Essure® removal in symptomatic patients may improve symptoms and quality of life. This should be discussed in the benefits and risks ratio before deciding on the best option of management.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9916818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Statement of Retraction [Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial]. 回撤声明[埃及剖腹产妇女胎盘后宫内节育器置入vs产褥期置入:1年随机对照试验]。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-08-01 DOI: 10.1080/13625187.2023.2198849

引用次数: 0

Expulsion and continuation rates of the 52 mg levonorgestrel intrauterine system in adolescents and adult women. 52 mg左炔诺孕酮在青少年和成年妇女宫内系统中的排出率和继续率。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-08-01 DOI: 10.1080/13625187.2023.2215366

Eliza Brull, Helymar C Machado, Luis Bahamondes, Cássia R T Juliato

{"title":"Expulsion and continuation rates of the 52 mg levonorgestrel intrauterine system in adolescents and adult women.","authors":"Eliza Brull, Helymar C Machado, Luis Bahamondes, Cássia R T Juliato","doi":"10.1080/13625187.2023.2215366","DOIUrl":"https://doi.org/10.1080/13625187.2023.2215366","url":null,"abstract":"Objective: To compare the continuation rates, expulsion, and other reasons for discontinuation of the hormonal intrauterine device with 52 mg of levonorgestrel (52 mg LNG-IUD) in adolescents and adult women.Methods: We conducted a retrospective cohort study that included 393 women in whom we placed a 52 mg LNG-IUD and followed up to 5 years. We created two retrospective cohorts, one with 131 adolescents (aged between 12 and 19 years) and the other with 262 women aged ≥20 years. Each adolescent was paired with two adult women who had the same parity and who had a 52 mg LNG-IUD inserted on the same day. We used the Mann-Whitney test to compare numerical variables in both groups, the Kaplan-Meier method, and the log-rank test to compare the continuation, expulsion and other reasons for IUD discontinuation of the two groups.Results: Age of the adolescents and adult women were mean ± SD 18.1 (±1.1) and 31 (±6.8) years, respectively (p = 0.015). Continuation rates by the fifth year of use were 55.6/100 women-years (W-Y) and 70.3/100 W-Y among adolescents and adult women (p = 0.106); and expulsion rates were 8.4/100 and 6.0/100 W-Y, respectively (p = 0.463). Adolescents had a lower continuation rate during 3 to 5 years of follow-up (p = 0.011) and a high rate of removals due to bleeding/pain (18.5 ± 5.7/100 W-Y vs 6.4/100 ± 2.1 W-Y, p = 0.039).Conclusion: Adolescents who used the 52 mg LNG-IUD showed a lower continuation rate 3-5 years after device placement than adult women. The expulsion rates were similar in both groups.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9864131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure^® implant removal: a cross-sectional study. Essure®植入物切除术后有症状患者的临床和组织病理学相关性：一项横断面研究。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-08-01 Epub Date: 2023-06-27 DOI: 10.1080/13625187.2023.2218953

Alexis Trecourt, Mojgan Devouassoux-Shisheboran, Erdogan Nohuz, Emanuele Cerruto, Stephanie Moret, Doriane Hallez, Chloe Miguet-Bensouda, Gautier Chene

{"title":"Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure® implant removal: a cross-sectional study.","authors":"Alexis Trecourt, Mojgan Devouassoux-Shisheboran, Erdogan Nohuz, Emanuele Cerruto, Stephanie Moret, Doriane Hallez, Chloe Miguet-Bensouda, Gautier Chene","doi":"10.1080/13625187.2023.2218953","DOIUrl":"10.1080/13625187.2023.2218953","url":null,"abstract":"Purpose: Many concerns have been raised about adverse effects related to Essure® device. Several pathophysiological hypotheses have been proposed including allergic reactions, Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants, galvanic corrosion with release of heavy metals and inflammation. In the present study, we aimed to focus on inflammation process by performing a histopathological evaluation of Fallopian tubes in symptomatic patients with Essure® removal.Materials and methods: A cross-sectional study with identification of the type of inflammatory response and characterisation of inflammatory cells in the surrounding tubal tissue around the Essure® (STTE) and at distance from the implant. Histopathological and clinical correlations were also investigated.Results: In the STTE from 47 cases, acute inflammation was observed in 3/47 (6.4%) cases. Chronic inflammation with lymphocytes (42.5%, 20/47) was associated with a significant higher pre-operative pain score (p = .03). Fibrosis was noted in 43/47 (91.5%) cases. Fibrosis without lymphocytes (51.1%, 24/47) was statistically associated with significant reduced pain (p = .04). At distance from the Essure® implant, only chronic inflammation with lymphocytes was present in 10/47 (21.7%) cases.Conclusions: Inflammation response do not seem to be enough to explain all the Essure-related adverse outcomes, suggesting the involvement of other biological mechanisms.Clinicaltrials.gov identifier: NCT03281564.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9858668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

The love-shaper: role of the foetus in modulating mother-child attachment through stem cell migration to the maternal brain. 爱的塑造者:胎儿通过干细胞迁移到母体大脑调节母子依恋的作用。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-08-01 DOI: 10.1080/13625187.2023.2216326

Mario Valerio Tartagni, Alessandra Graziottin

{"title":"The love-shaper: role of the foetus in modulating mother-child attachment through stem cell migration to the maternal brain.","authors":"Mario Valerio Tartagni, Alessandra Graziottin","doi":"10.1080/13625187.2023.2216326","DOIUrl":"https://doi.org/10.1080/13625187.2023.2216326","url":null,"abstract":"Background: Foetal PAPCs (pregnancy-associated progenitor cells) begin to cross the placenta in a scheduled manner from early pregnancy and colonise many maternal organs, both in mammals and humans, during each pregnancy. The maternal limbic system appears to be colonised with a 100% frequency when compared with other maternal organs. Once they arrive in the limbic system, foetal PAPCs differentiate into neurons and glial cells, resulting in the formation of new synapses with and among maternal neurons. This process is accompanied by major structural neurobiological alterations orchestrated by hormonal changes characteristic of gestation and involves the limbic system, reward areas, and other closely connected brain structures, i.e., the same areas colonised by foetal PAPCs.Objective: To correlate findings regarding microscopic and macroscopic changes induced by foetal stem cell migration into the maternal limbic system and hormonal surges during pregnancy with the biological basis of mother-child attachment dynamics, with a focus on the clinical implications this discovery has for normal, complicated, and assisted pregnancies.Evidence review: A literature review of evidence regarding the neuroanatomical correlation between the targeted, colonising migration of foetal PAPCs into the maternal brain and the structural neurobiological alterations within the affective areas related to attachment and reward was conducted.Results and conclusions: These findings suggest a synergic effect of cellular and morphological changes, with a common biological aim of conferring an adaptive advantage in motherhood, and with the foetus playing a surprisingly active role in modulating the mother's ability to love and care for it.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9915297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The impact of combined contraceptive vaginal ring on vaginal environment: an observational, longitudinal study. 联合避孕环对阴道环境的影响:一项观察性的纵向研究。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-08-01 DOI: 10.1080/13625187.2023.2228440

Filippo Murina, Alessandra Graziottin, Stefania Di Francesco, Dario Recalcati

{"title":"The impact of combined contraceptive vaginal ring on vaginal environment: an observational, longitudinal study.","authors":"Filippo Murina, Alessandra Graziottin, Stefania Di Francesco, Dario Recalcati","doi":"10.1080/13625187.2023.2228440","DOIUrl":"https://doi.org/10.1080/13625187.2023.2228440","url":null,"abstract":"Purpose: To assess the relationship between combined contraceptive vaginal ring (CVR) and vaginal microbiome using 16S rRNA gene sequencing.Materials and methods: We enrolled 20 women for 8 weeks in an open-label study using CVR (NuvaRing®) that delivered 15 mcg ethinylestradiol and 120 mcg etonogestrel daily. The vaginal microbiome was assessed at baseline and after 2 months by sequencing the 16S rRNA genes amplified from the total genomic DNA isolated from the sample.Results: Bacterial distribution richness and equity did not significantly change after 2 months, and the dominant bacterial strain was Lactobacillus crispatus. Only one woman with a history of vestibulodynia and recurrent vulvovaginitis showed an increase in bacterial biodiversity, with a switch to the relative abundance of anaerobic bacteria.Conclusions: Our results suggest that CVR does not adversely affect the composition and structure of the vaginal microbiome. However, special care should be taken in patients with a history of vestibulodynia and/or recurrent vulvovaginal infections.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9861883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

High-intensity focussed ultrasound and hysteroscopy endo-operative system cold device procedures for treating >4cm diameter FIGO Type 2 uterine myoma and ensuring successful pregnancy. 高强度聚焦超声和宫腔镜术内系统冷装置治疗>4cm直径FIGO 2型子宫肌瘤，确保妊娠成功。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-08-01 DOI: 10.1080/13625187.2023.2216329

Sha Liao, Xiaoli Wang, Na Fu, Yan Huang

{"title":"High-intensity focussed ultrasound and hysteroscopy endo-operative system cold device procedures for treating >4cm diameter FIGO Type 2 uterine myoma and ensuring successful pregnancy.","authors":"Sha Liao, Xiaoli Wang, Na Fu, Yan Huang","doi":"10.1080/13625187.2023.2216329","DOIUrl":"https://doi.org/10.1080/13625187.2023.2216329","url":null,"abstract":"Purpose: Laparotomic or hysteroscopic myomectomy, and high-intensity focussed ultrasound (HIFU), can be used in the treatment of Type 2 myomas with a > 50% intramural component. Hysteroscopic electroresection may damage the remaining endometrium and complete ablation of myomas may not be realised via HIFU treatment. We report and examine the results of 1 case of HIFU treatment, accompanied with the hysteroscopy endo-operative system (HEOS) cold device procedure.Materials and methods: These were used for treating a > 4cm diameter Type 2 uterine myoma and ensuring successful pregnancy. HIFU treatment of uterine myomas can achieve point-by-point ablation of lesions as far as possible without damaging the endometrium. The HEOS cold device procedure was implemented 3 months after HIFU treatment.Results: The patient got pregnant naturally in the third month after receiving treatment, with no complications during her pregnancy. The patient gave birth to a healthy male via full-term cesarean section.Conclusions: HIFU treatment, accompanied with the HEOS cold device procedure, ensured complete myoma removal. It also preserved the integrity of the myometrium and prevented uterine perforation during surgery.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9865542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Keeping you posted: analysis of fertility-related social media posts after introduction of the COVID-19 vaccine. 让你随时关注:对引入COVID-19疫苗后与生育相关的社交媒体帖子的分析

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-06-01 DOI: 10.1080/13625187.2023.2189501

Jillian Pecoriello, Nicole Yoder, Meghan B Smith, Jennifer K Blakemore

{"title":"Keeping you posted: analysis of fertility-related social media posts after introduction of the COVID-19 vaccine.","authors":"Jillian Pecoriello, Nicole Yoder, Meghan B Smith, Jennifer K Blakemore","doi":"10.1080/13625187.2023.2189501","DOIUrl":"https://doi.org/10.1080/13625187.2023.2189501","url":null,"abstract":"Purpose: Our objective was to analyse information and sentiments posted regarding the COVID-19 vaccine on fertility-related social media.Materials and methods: The first fifty accounts on Instagram and Twitter were identified with the terms: fertility doctor, fertility, OBGYN, infertility, TTC, IVF. Accounts were categorised as physician (PH), individual (ID), or fertility center/organisation (FCO). The vaccine was approved on 12/11/2020 and Instagram and Twitter posts dated 12/1/2020 - 2/28/2021 were reviewed. Posts were analysed for sentiment, mention of research studies (RS), national guidelines (NG), personal experience (PE), side effects (SE), reproductive related (RR) content and activity, including likes and comments.Results: A total of 276 accounts were included. Sentiments towards the vaccine were largely positive (PH 90.3%, ID 71.4%, FCO 70%), or neutral (PH 9.7%, ID 28.6%, FCO 30%). Instagram accounts showed an increase in activity on vaccine posts compared to baseline by likes (PH 4.86% v 3.76%*, ID 7.5% v 6.37%*, FCO 2.49% v 0.52%*) and comments (PH 0.35% v 0.28%, ID 0.90% v 0.69%,* FCO 0.10% v 0.02%*).Conclusion: Most posts expressed positive sentiments towards the vaccine. Evaluating the sentiment of the COVID-19 vaccine as it relates to fertility on social media represents an opportunity for understanding both the patient's and health care professional's opinion on the subject. Given the potential devastating effects of misinformation on public health parameters, like vaccination, social media offers one avenue for healthcare professionals to engage online and work to make their presences more effective and influential.SHORT CONDENSATIONThis article analyses content and sentiments posted regarding the COVID-19 vaccine on fertility-related social media in order to offer a deeper understanding of available information and beliefs.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9603076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Assessment of pain and ease of intrauterine device placement according to type of device, parity, and mode of delivery. 根据装置类型、胎次和分娩方式评估宫内节育器放置的疼痛和容易程度。

IF 1.7 4区医学

European Journal of Contraception and Reproductive Health Care Pub Date : 2023-06-01 DOI: 10.1080/13625187.2023.2189500

Elaine A Lopes-Garcia, Elenice V Carmona, Ilza Monteiro, Luis Bahamondes

{"title":"Assessment of pain and ease of intrauterine device placement according to type of device, parity, and mode of delivery.","authors":"Elaine A Lopes-Garcia, Elenice V Carmona, Ilza Monteiro, Luis Bahamondes","doi":"10.1080/13625187.2023.2189500","DOIUrl":"https://doi.org/10.1080/13625187.2023.2189500","url":null,"abstract":"Objective: We compared pain and the ease of insertion of two different types of intrauterine devices (IUDs; the levonorgestrel intrauterine systems 52 mg (LNG-IUS 52 mg) and the copper-bearing IUD [TCu380A]) among nulligravidas and parous women with and without caesarean delivery.Methods: A cross-sectional study assessed pain referred by women and ease of insertion of the two IUDs models. We applied a visual analogue scale (VAS) to assess pain, while the ease of insertion was defined by healthcare professionals.Results: We assessed 1076 women, including 334 nulligravidas and 566 parous women who had had at least one caesarean delivery and 176 women with history of only vaginal delivery. Regarding pain at IUD placement, 26 (2.5%) women reported no pain, 167 (16.4%) light pain, 319 (31.3%) moderate and 506 (49.7%) intense pain. The highest scores for pain were reported by nulligravidas (67.2%, p = 0.001), while the mean pain score was higher in the LNG-IUS 52 mg group. Difficulties reported by healthcare providers were more frequent in the nulligravidas (21.2%) and women with previous caesarean delivery (16.9%).Conclusions: Our findings suggested differences between the two IUDs tested, with higher pain associated with the LNG-IUS 52 mg, and highlights the need for pain management, mainly among nulligravida and women with history of caesarean delivery.SHORT CONDENSATIONIntense pain at insertion was more related to nulligravida than parous women and more pain with placement of LNG-IUS 52 mg IUDs than TCu380A IUDs. Nevertheless, our results confirmed that ease of IUD placement was between 80% to 90% of all insertions, being more common in parous women without previous caesarean delivery.","PeriodicalId":50491,"journal":{"name":"European Journal of Contraception and Reproductive Health Care","volume":null,"pages":null},"PeriodicalIF":1.7,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9604472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0